Regeneron Files Antitrust Lawsuit Accusing Amgen Of Engaging In A Persistent Exclusionary Campaign To Deny Patients Access To Praluent® – Antitrust, EU Competition
03 June 2022 Goodwin Procter LLP To print this article, all you need is to be registered or login on Mondaq.com. Late last week, Regeneron Pharmaceuticals, Inc. filed an antitrust complaint against Amgen Inc. in the US District Court for the District of Delaware. Regeneron alleges that “Amgen is engaged in a persistent…